AlphaMol combines computational biology, biochemistry, medicinal chemistry, pharmacology, biotechnology and others subjects together, aiming at building up a complete pipeline to advance modern new drug discovery and drug design in an ultimately efficient way. The members of AlphaMol advanced two "first-in-class" drug molecules into clinical trial via computational methods within three years, of which the world-wide patents were granted. Moreover, the members of AlphaMol also invented a series of important biotechnology in the past 20 years. AlphaMol establishes an international outstanding team to make milestones in the areas of both drug discovery and biotechnology.